R. Siekmeier
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
-
- Inhalation and Respiratory Drug Delivery
- Cystic Fibrosis Research Advances
Papers in
-
- Inhalation and Respiratory Drug Delivery 10
- Cystic Fibrosis Research Advances 5
-
- Asthma and respiratory diseases 5
- Co-authors
- G. Scheuch (8 shared papers)Peter Brand (4 shared papers)Martin Kohlhäeufl (1 shared paper)R. Horré (3 shared papers)Sybren de Hoog (1 shared paper)J�rgen Stegemann (1 shared paper)Anthony J. Fischer (1 shared paper)K. P. Schaal (1 shared paper)
- Journals
- Respiration (2 papers)Advanced Drug Delivery Reviews (1 paper)Journal of Cardiovascular Pharmacology and Therapeutics (1 paper)Mycoses (1 paper)Experimental Lung Research (1 paper)
- Partner nations
- GermanyUnited StatesJapan
In The Last Decade
R. Siekmeier
17 papers receiving 568 citations
Peers
Comparison fields: 5 of 84
- Pharmaceutical Science 64
- Pulmonary and Respiratory Medicine 297
- Infectious Diseases 111
- Transplantation 6
- Food Science 44
Countries citing papers authored by R. Siekmeier
This map shows the geographic impact of R. Siekmeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Siekmeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Siekmeier more than expected).
Fields of papers citing papers by R. Siekmeier
This network shows the impact of papers produced by R. Siekmeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Siekmeier. The network helps show where R. Siekmeier may publish in the future.
Co-authors
The 25 scholars most cited alongside R. Siekmeier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 128 | |
| 2 | 2004 | 72 | |
| 3 | Novel approaches to enhance pulmonary delivery of proteins and peptides. | 2007 | 56 |
| 4 | 2009 | 48 | |
| 5 | 2002 | 47 | |
| 6 | 2008 | 40 | |
| 7 | Lipoprotein (a) and risk of cardiovascular disease--a systematic review and meta analysis of prospective studies. | 2011 | 35 |
| 8 | 2001 | 29 | |
| 9 | 2000 | 22 | |
| 10 | 2013 | 21 | |
| 11 | Treatment of systemic diseases by inhalation of biomolecule aerosols. | 2009 | 20 |
| 12 | Inhalation of tobramycin in patients with cystic fibrosis: comparison of two methods. | 2007 | 16 |
| 13 | 2010 | 12 | |
| 14 | Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects. | 2007 | 12 |
| 15 | 2003 | 11 | |
| 16 | 2010 | 10 | |
| 17 | Aerosol therapy during non-invasive mechanical ventilation: Review of key technical factors and clinical implications | 2013 | 4 |
About R. Siekmeier
R. Siekmeier is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Infectious Diseases, Surgery and Pediatrics, Perinatology and Child Health, having authored 17 papers that have together received 583 indexed citations. Recurring topics across this work include Inhalation and Respiratory Drug Delivery (10 papers), Cystic Fibrosis Research Advances (5 papers), Asthma and respiratory diseases (5 papers), Antifungal resistance and susceptibility (2 papers), Lipoproteins and Cardiovascular Health (2 papers), Pharmaceutical studies and practices (2 papers), Pharmaceutical Practices and Patient Outcomes (1 paper) and Venous Thromboembolism Diagnosis and Management (1 paper). The work is most often cited by research in Pharmaceutical Science (64 citations), Pulmonary and Respiratory Medicine (297 citations), Infectious Diseases (111 citations), Transplantation (6 citations) and Food Science (44 citations). R. Siekmeier has collaborated with scholars based in Germany, United States and Japan. Frequent co-authors include G. Scheuch, Peter Brand, Martin Kohlhäeufl, R. Horré, Sybren de Hoog, J�rgen Stegemann, Anthony J. Fischer, K. P. Schaal, Norbert Schnitzler and G. Marklein. Their work appears in journals such as Respiration, Advanced Drug Delivery Reviews, Journal of Cardiovascular Pharmacology and Therapeutics, Mycoses and Experimental Lung Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.